although revenu came light sequel ii placement strong
expect consum revenu affect custom transit sequel ii
compani appear execut well period acquisit uncertainti capit
constraint recal conclud propos acquisit may lessen competit
believ complet deal unlik
report revenu y/i miss estim
consensu compani record instrument
revenu consum revenu compani note place sequel
ii instrument septemb sequel ii placements/upgrad track slightli
estim still good manag indic consum revenu
took hit due consum transit sequel sequel ii also get sens
pend acquisit meaning impact positive/neg
placement thu far manag continu execut well even capital-
gross margin consensu
estim believ primarili due increas instrument placement lower
pull-through consum transit sequel sequel ii encouragingli
also confirm increas sequel ii demand spike posit
trend consum demand think rate sustain howev clear
manag expenses/invest growth septemb
unrestrict cash cash equival invest total said
note elig cash payment
sequel ii seem perform well rel target specif compani
appear well posit continu produc instrument consum
accept margins/yield encourag progress front next
logic step stand-alon would seemingli boost evolv commerci
infrastructur success navig point confid sequel ii
manufactur perform target arguabl constrain due
pend acquisit
octob uk releas provision find propos ilmn/pacb
merger conclud deal might result lessen competit
remedi like prohibit merger detail pleas refer
note believ deal highli unlik complet
pleas see page report import disclosur
year stagnant growth variou level success meet timelin
target believ verg revenu growth inflect launch
sequel ii instrument compani smrt technolog alway attract
attribut rel sequenc approach less bia longer read length
chip compani longer lag meaning behind technolog
key metric cost per gigabas throughput per run drive earli
adopt newli launch chip instrument littl doubt system
see meaning uptak drive inflect revenu growth
inflect y/i
follow chip launch
progress improv gross
margin reduct opex similar
previou quarter
chip catalyz demand strongli
anticip drive
placement upgrad forecast
util sequel instrument exce
due custom ramp
quickli expect shift
workflow instrument
chip instrument product
issu caus miss timelin
chip instrument
catalyz demand expect due high
capit cost poorer expect
life scienc tool compani current market
sequel sequenc platform backbon compani sequenc platform
call smrt single-molecul real-tim technolog via smrt pacbio aim address
mani limit sequenc technolog includ short read length limit
flexibl long time result complex sampl prepar risk amplif bia
unfortun sinc compani found uptak pacbio sequenc
rel limit due number delay lag perform cost/spe limit
compani aim chang recent launch sequel chip
perform promis believ smrt sequenc technolog
potenti final adopt truli differenti commerci
attract product especi metric read length epigenet detect
cowen compani
cowen vs consensu mm except revenu metric mm except statement mm except per count instrument revenu y/i forecast compani instal total sequel ii instrument septemb consum revenu y/i forecast compani believ decreas consum revenu driven lower pull sequel instrument custom transit sequel sequel iiservic revenu y/i touch forecast expens smidg forecast sg expens slightli forecast believ need continu invest sale forc market support new sequenc revenu y/i miss estim consensu sequel ii placements/upgrad track estim consum revenu took hit transit sequel sequel gross margin consensu estim gross margin decreas q/q cowen
compani report cowen compani
mm except cagrcommentstot instrument consum total instal total instal instrument list instal instal instrument growth list instal instal ship sequel ii system custom beyond eap april growth ii instrument growth list instal instal ship sequel ii system custom beyond eap april growth materi manufactur constraint time similar suppli chain consum consum support consum annuiti stream consum consum annuiti stream growth servic support list price contract instrument servic revenu servic list contract instrument servic revenu sequel still avail demand pretti low payback sequel ii pretti quick aug move around lot especi earli differ thing differ custom distributor impact trade-aug could variabl throughout depend pace placement stock note new chemistri usual come cowen
compani report thomson eikon cowen compani
new normal point develop activ expect continu similar level gener sg spend increas a/leg driven increase/quart like continu effort request oper salesnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmdepreci income/expens interest count mm gross oper consensu estim cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit commerci roll-out chip delay
perform wors anticip greater-than-expect reduct academ
govern research fund competit commerci avail potenti
disrupt technolog price pressur caus competit increas demand
lower-pr instrument run-tim cost neg regulatori dynam
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc novemb et dissemin novemb et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
